116 related articles for article (PubMed ID: 34190187)
21. Phase-specific and lifetime economic burden of cervical cancer and endometrial cancer in a commercially insured United States population.
Shah R; Corman S; Shah A; Kebede N; Nwankwo C
J Med Econ; 2021; 24(1):1221-1230. PubMed ID: 34686073
[TBL] [Abstract][Full Text] [Related]
22. Overview of methods to estimate the medical costs of cancer.
Barlow WE
Med Care; 2009 Jul; 47(7 Suppl 1):S33-6. PubMed ID: 19536013
[TBL] [Abstract][Full Text] [Related]
23. Healthcare Costs Associated with an Adequate Intake of Sugars, Salt and Saturated Fat in Germany: A Health Econometrical Analysis.
Meier T; Senftleben K; Deumelandt P; Christen O; Riedel K; Langer M
PLoS One; 2015; 10(9):e0135990. PubMed ID: 26352606
[TBL] [Abstract][Full Text] [Related]
24. Societal cost of cancer in Norway -Results of taking a broader cost perspective.
Bugge C; Sæther EM; Brustugun OT; Kristiansen IS
Health Policy; 2021 Aug; 125(8):1100-1107. PubMed ID: 34088521
[TBL] [Abstract][Full Text] [Related]
25. The Societal Costs of Schizophrenia in Switzerland.
Pletscher M; Mattli R; von Wyl A; Reich O; Wieser S
J Ment Health Policy Econ; 2015 Jun; 18(2):93-103. PubMed ID: 26231000
[TBL] [Abstract][Full Text] [Related]
26. Estimation of Life-Year Loss and Lifetime Costs for Different Stages of Colon Adenocarcinoma in Taiwan.
Chen PC; Lee JC; Wang JD
PLoS One; 2015; 10(7):e0133755. PubMed ID: 26207912
[TBL] [Abstract][Full Text] [Related]
27. Age, risk, and life expectancy in Norwegian intensive care: a registry-based population modelling study.
Lindemark F; Haaland ØA; Kvåle R; Flaatten H; Johansson KA
PLoS One; 2015; 10(5):e0125907. PubMed ID: 26011281
[TBL] [Abstract][Full Text] [Related]
28. Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer.
Ramsey SD; Berry K; Etzioni R
Am J Gastroenterol; 2002 Feb; 97(2):440-5. PubMed ID: 11866285
[TBL] [Abstract][Full Text] [Related]
29. Lifetime survival and medical costs of lung cancer: a semi-parametric estimation from South Korea.
Park HY; Hwang J; Kim DH; Jeon SM; Choi SH; Kwon JW
BMC Cancer; 2020 Sep; 20(1):846. PubMed ID: 32883237
[TBL] [Abstract][Full Text] [Related]
30. Economic burden of multiple sclerosis in France estimated from a regional medical registry and national sick fund claims.
Bruno D; Marc D; Ouarda P; Dominique S; Marc S; Laurène C; Khalil J; Jonathan E; Francis G
Mult Scler Relat Disord; 2019 Nov; 36():101396. PubMed ID: 31525627
[TBL] [Abstract][Full Text] [Related]
31. Costs of cancer along the care continuum: What we can expect based on recent literature.
Pisu M; Henrikson NB; Banegas MP; Yabroff KR
Cancer; 2018 Nov; 124(21):4181-4191. PubMed ID: 30475400
[TBL] [Abstract][Full Text] [Related]
32. Expected 10-year treatment cost of breast cancer detected within and outside a public screening program in Norway.
Moger TA; Bjørnelv GM; Aas E
Eur J Health Econ; 2016 Jul; 17(6):745-54. PubMed ID: 26239280
[TBL] [Abstract][Full Text] [Related]
33. Estimating Life Expectancy and Lifetime Healthcare Costs for Alzheimer's Disease in Taiwan: Does the Age of Disease Onset Matter?
Yeh TS; Wang JD; Ku LE
J Alzheimers Dis; 2020; 73(1):307-315. PubMed ID: 31771049
[TBL] [Abstract][Full Text] [Related]
34. The societal costs of intracerebral hemorrhage in Spain.
Navarrete-Navarro P; Hart WM; Lopez-Bastida J; Christensen MC
Eur J Neurol; 2007 May; 14(5):556-62. PubMed ID: 17437616
[TBL] [Abstract][Full Text] [Related]
35. Incidence-based cost-of-illness model for metastatic breast cancer in the United States.
Sorensen SV; Goh JW; Pan F; Chen C; Yardley D; Martín M; Knopf K; Benedict A; Giorgetti C; Iyer S
Int J Technol Assess Health Care; 2012 Jan; 28(1):12-21. PubMed ID: 22617734
[TBL] [Abstract][Full Text] [Related]
36. Economic cost of tobacco-related cancers in Sri Lanka.
Amarasinghe H; Ranaweera S; Ranasinghe T; Chandraratne N; Kumara DR; Thavorncharoensap M; Abeykoon P; de Silva A
Tob Control; 2018 Sep; 27(5):542-546. PubMed ID: 29079585
[TBL] [Abstract][Full Text] [Related]
37. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
38. Cost and health consequences of treatment of primary biliary cirrhosis with ursodeoxycholic acid.
Boberg KM; Wisløff T; Kjøllesdal KS; Støvring H; Kristiansen IS
Aliment Pharmacol Ther; 2013 Oct; 38(7):794-803. PubMed ID: 23915021
[TBL] [Abstract][Full Text] [Related]
39. Phase-specific healthcare costs of cervical cancer: estimates from a population-based study.
Liu N; Mittmann N; Coyte PC; Hancock-Howard R; Seung SJ; Earle CC
Am J Obstet Gynecol; 2016 May; 214(5):615.e1-615.e11. PubMed ID: 26627729
[TBL] [Abstract][Full Text] [Related]
40. Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data.
Lang K; Lines LM; Lee DW; Korn JR; Earle CC; Menzin J
Clin Gastroenterol Hepatol; 2009 Feb; 7(2):198-204. PubMed ID: 18849013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
